BIOL - BIOLASE, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.325
-0.005 (-1.426%)
At close: 3:55PM EDT
Stock chart is not supported by your current browser
Previous Close0.330
Open0.340
Bid0.305 x 10700
Ask0.500 x 500
Day's Range0.306 - 0.340
52 Week Range0.280 - 1.450
Volume153,686
Avg. Volume140,168
Market Cap33.264M
Beta1.08
PE Ratio (TTM)N/A
EPS (TTM)-0.282
Earnings DateMay 1, 2018 - May 7, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2005-06-24
1y Target Est1.10
Trade prices are not sourced from all markets
  • PR Newswire5 days ago

    BIOLASE Establishes Southern California Dental Advisory Board

    Industry leaders join forces to deliver thought leadership on laser dentistry and improve patient outcomes IRVINE, Calif. , April 17, 2018 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader ...

  • PR Newswire11 days ago

    BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options

    IRVINE, Calif., April 11, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the world's leading manufacturer and distributor of dental lasers and a pioneer in laser surgery in other medical specialties, today announced that its Board of Directors ("Board") has asked Jonathan T. Lord, M.D., Chairman of the Board of BIOLASE, to lead the Company's exploration of a wide range of strategic alternatives, as well as the implementation of the recent Southern California initiatives to significantly enhance the region's oral health and dental care by increasing awareness and education in laser dentistry. The Board has also appointed Chief Financial Officer John R. Beaver as Interim Chief Executive Officer to focus on business performance improvement and continuing operational efficiencies.  Mr. Beaver replaces Harold C. Flynn, Jr., who has resigned from his positions as President, Chief Executive Officer and Director of the Company to pursue other interests.

  • PR Newswire18 days ago

    BIOLASE Names Garrett Sato To Board Of Directors

    IRVINE, Calif. , April 4, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has named veteran dental industry and financial services executive ...

  • PR Newswire25 days ago

    BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry

    IRVINE, Calif., March 28, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that the demand for pain-free care increases as awareness of the  more patient-friendly benefits of using dental lasers is growing in pediatric dentistry. With BIOLASE all-tissue dental lasers, pediatric dentists can treat even their youngest patients with little to no anesthesia, allowing dentists to intervene earlier in the management of children's dental conditions, such as tooth decay. Minimally invasive treatment with a dental laser allows for increased patient acceptance of treatment and practice growth.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of BIOL earnings conference call or presentation 14-Mar-18 8:30pm GMT

    Q4 2017 BIOLASE Inc Earnings Call

  • Associated Presslast month

    Biolase reports 4Q loss

    On a per-share basis, the Irvine, California-based company said it had a loss of 5 cents. Losses, adjusted for stock option expense and non-recurring costs, came to 4 cents per share. The maker of dental ...

  • PR Newswirelast month

    BIOLASE Reports 2017 Fourth Quarter And Full-Year Results

    IRVINE, Calif. , March 14, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for its fourth quarter and year ended December 31, ...

  • ACCESSWIRElast month

    BIOLASE, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 14, 2018 / BIOLASE, Inc. (NASDAQ: BIOL ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 14, 2018, at 4:30 PM Eastern Time. To ...

  • Is It Too Late To Buy BIOLASE Inc (NASDAQ:BIOL)?
    Simply Wall St.last month

    Is It Too Late To Buy BIOLASE Inc (NASDAQ:BIOL)?

    BIOLASE Inc (NASDAQ:BIOL), a medical equipment company based in United States, led the NasdaqCM gainers with a relatively large price hike in the past couple of weeks. Less-covered, small capsRead More...

  • PR Newswire2 months ago

    BIOLASE Secures $6 Million Revolving Line Of Credit

    IRVINE, Calif., March 7, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it has secured a $6 million revolving line of credit from Bridge Bank, a division of Western Alliance Bank. Funds from the two-year accounts receivable line of credit will be used for working capital purposes.

  • PR Newswire2 months ago

    BIOLASE® To Host 2017 Fourth Quarter Financial Results Conference Call On March 14, 2018

    IRVINE, Calif. , March 6, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Wednesday, March 14, 2018 ...

  • PR Newswire2 months ago

    BIOLASE Announces Memorandum Of Understanding With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Device

    IRVINE, Calif., Feb. 27, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it has executed a non-binding Memorandum of Understanding ("MOU") with Redmond, WA-based S-Ray Incorporated ("S-Ray") to exclusively market and sell S-Ray's patented ClearView SCAN™ system, a disruptive and innovative ultrasound-based intraoral imaging system in the North American dental markets. ClearView SCAN is designed to be adjunct radiation-free imaging for soft-tissue anatomy that radiographs fail to detect, delivering a new category of imaging capability to clinicians for diagnosis and treatment planning. The MOU, which is subject to the negotiation and execution of a definitive agreement between BIOLASE and S-Ray, covers the multi-year terms of the exclusive distribution and service arrangement for the ClearView SCAN system.

  • PR Newswire2 months ago

    BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California

    IRVINE, Calif., Feb. 15, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, announced today that it is bolstering its efforts in Southern California to significantly enhance the region's oral health and dental care by increasing awareness and education in laser dentistry. BIOLASE is adding local specialists to its staff to offer dentists more support in maximizing the use of their lasers.

  • PR Newswire2 months ago

    Nasdaq Grants BIOLASE 180-Day Extension To Meet Minimum Bid Price Requirement

    IRVINE, Calif. , Feb. 7, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser company, today announced that the Listing Qualifications Department of the Nasdaq Stock Market ...

  • PR Newswire3 months ago

    BIOLASE Rejects Frivolous, Abusive Patent Litigation

    IRVINE, Calif., Jan. 25, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the world's leading dental laser company, today released the following statement in response to the latest attempt by CAO Group, Inc. to use patent litigation to try to improve its competitive position in the marketplace. BIOLASE is well-known for its own innovations, and for respecting the valid intellectual property rights of others. It is not surprising that CAO has failed for years in its attempts to intimidate BIOLASE through abusive patent litigation.

  • PR Newswire3 months ago

    CAO Group, Inc. Protects Its Diode Laser Patent Rights From Infringement By Biolase, Inc.

    SALT LAKE CITY , Jan. 24, 2018 /PRNewswire/ -- CAO Group, Inc. (CAO) has filed patent infringement lawsuits in the United States District Court for the State of Utah and in the United States District Court ...

  • PR Newswire4 months ago

    BIOLASE Receives Awards From Leading Industry Organizations For Its Dental Laser Systems

    IRVINE, Calif., Jan. 4, 2018 /PRNewswire/ -- BIOLASE, Inc. (BIOL), the global leader in dental lasers, today announced that it has received awards for three of its dental laser systems. The Waterlase Express™ received the Dr. Bicuspid Dental Excellence Award as best new dental product in the equipment category. "Recognition by three of the dental industry's most widely recognized and respected information resources is a testament to our commitment to delivering the most advanced technologies to dentists, which enable them to provide the highest level of care to their patients," said Harold C. Flynn Jr., president and CEO of BIOLASE.

  • Capital Cube4 months ago

    ETFs with exposure to BIOLASE, Inc. : December 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to BIOLASE, Inc. Here are 5 ETFs with the largest exposure to BIOL-US. Comparing the performance and risk of BIOLASE, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire5 months ago

    BIOLASE Announces Expiration of Rights Offering

    BIOLASE, Inc. , the global leader in dental lasers, announced today that the subscription period for its previously announced rights offering to holders of shares of its common stock expired at 5:00 p.m., Eastern Time, on November 29, 2017, and these rights are no longer exercisable.

  • Business Wire5 months ago

    BIOLASE to Conduct Demos of Portable Waterlase Express™ All-Tissue Laser System at Greater New York Dental Meeting

    BIOLASE, Inc. , the global leader in dental lasers, announced today that it will be conducting demonstrations of its recently launched Waterlase Express all-tissue laser system at the Greater New York Dental Meeting next week at the Jacob K.

  • Capital Cube5 months ago

    ETFs with exposure to BIOLASE, Inc. : November 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to BIOLASE, Inc. Here are 5 ETFs with the largest exposure to BIOL-US. Comparing the performance and risk of BIOLASE, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ACCESSWIRE5 months ago

    BIOLASE to Present at the LD Micro 10th Annual Main Event Conference

    LOS ANGELES, CA / ACCESSWIRE / November 17, 2017 / BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 10th annual LD Main Event conference ...

  • Business Wire5 months ago

    BIOLASE to Present at the Singular Research Best of the Uncovered 12th Annual Conference 2017

    BIOLASE, Inc. , the global leader in dental lasers, today announced that it is scheduled to present at the Singular Research Best of the Uncovered 12th Annual Conference 2017 on Monday, December 4, 2017, at 3:00 PM Pacific Time.